Mads Kirchheiner Rasmussen

Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis

Alexander Egeberg, Mathias Bo Ottosen, Robert Gniadecki et al. · British Journal of Dermatology · 2017 · 282 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

Alexander Egeberg, Nana Aviaaja Lippert Rosenø, David Thein et al. · Seminars in Arthritis and Rheumatism · 2022 · 87 citations

Medicine, Immunology, Pharmacology +17

The MeteoMet project – metrology for meteorology: challenges and results

Andrea Merlone, Giuseppina Lopardo, Francesca Sanna et al. · Meteorological Applications · 2015 · 86 citations · Full text

Engineering, Earth Sciences, Meteorology +14

Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid

Line Kibsgaard, Mads Kirchheiner Rasmussen, A. Lamberg et al. · British Journal of Dermatology · 2017 · 84 citations

Medicine, Neurology, Clinical Epidemiology +16

Dimethylfumarate Specifically Inhibits the Mitogen and Stress-Activated Kinases 1 and 2 (MSK1/2): Possible Role for its Anti-Psoriatic Effect

Borbala Gesser, Claus Johansen, Mads Kirchheiner Rasmussen et al. · Journal of Investigative Dermatology · 2007 · 68 citations

Life Sciences, Medicinal Chemistry, Pharmacology +11